
The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains
It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With blood from healthy donors, Nkarta isolates immune cells …